Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T16:17:43.762Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:17:43.762Z.

Quote observation: 2026-10-06T16:15:08.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 171,618,552
Total debt · period ending 2026-06-30: 9,537,000
Cash · period ending 2026-06-30: 4,344,000
TTM free cash flow · period ending 2026-06-30: -28,385,250

FMP input reference: 691567571024a1250b647fc32e699128e911e71d0d99b5189d978a843a850df9

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

MDWD EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

EV/FCF RATIO AVG TTM

N/A

EV/FCF RATIO AVG 3Y

N/A

EV/FCF RATIO AVG 5Y

N/A

EV/FCF RATIO AVG 10Y

N/A

EV/FCF RATIO AVG 15Y

N/A

EV/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

MDWD Competitors' EV/FCF Ratio

MDWD

MediWound Ltd.

Current

Market Cap

$171.62M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ORGO

Organogenesis Holdings Inc.

vs MDWD

Market Cap

$169.85M

EV/FCF Ratio

9.15x

TTM Avg

14.67x

3Y Avg

65.56x

5Y Avg

51.74x

PRQR

ProQR Therapeutics N.V.

vs MDWD

Market Cap

$173.23M

EV/FCF Ratio

N/A

TTM Avg

3.88x

3Y Avg

3.88x

5Y Avg

3.88x

CUE

Cue Biopharma, Inc.

vs MDWD

Market Cap

$173.79M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NKTX

Nkarta, Inc.

vs MDWD

Market Cap

$173.38M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DTIL

Precision BioSciences, Inc.

vs MDWD

Market Cap

$173.98M

EV/FCF Ratio

N/A

TTM Avg

277.79x

3Y Avg

277.79x

5Y Avg

277.79x

OPRX

OptimizeRx Corp.

vs MDWD

Market Cap

$165.58M

EV/FCF Ratio

8.77x

TTM Avg

14.69x

3Y Avg

48.91x

5Y Avg

45.02x

CMPX

Compass Therapeutics, Inc.

vs MDWD

Market Cap

$176.36M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CHRS

Coherus Oncology, Inc.

vs MDWD

Market Cap

$163.00M

EV/FCF Ratio

N/A

TTM Avg

568.17x

3Y Avg

568.17x

5Y Avg

88.75x

QTRX

Quanterix Corporation

vs MDWD

Market Cap

$164.16M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
MediWound Ltd. (MDWD)	$171.62M	N/A	N/A	N/A	N/A
Organogenesis Holdings Inc. (ORGO)vs ›	$169.85M	9.15x	14.67x	65.56x	51.74x
ProQR Therapeutics N.V. (PRQR)vs ›	$173.23M	N/A	3.88x	3.88x	3.88x
Cue Biopharma, Inc. (CUE)vs ›	$173.79M	N/A	N/A	N/A	N/A
Nkarta, Inc. (NKTX)vs ›	$173.38M	N/A	N/A	N/A	N/A
Precision BioSciences, Inc. (DTIL)vs ›	$173.98M	N/A	277.79x	277.79x	277.79x
OptimizeRx Corp. (OPRX)vs ›	$165.58M	8.77x	14.69x	48.91x	45.02x
Compass Therapeutics, Inc. (CMPX)vs ›	$176.36M	N/A	N/A	N/A	N/A
Coherus Oncology, Inc. (CHRS)vs ›	$163.00M	N/A	568.17x	568.17x	88.75x
Quanterix Corporation (QTRX)vs ›	$164.16M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

MDWD EV/FCF Ratio History

DATE	EV/FCF RATIO
2020-06-30	10.51x
2020-06-29	9.36x
2020-06-26	9.40x
2020-06-25	9.66x
2020-06-24	9.32x
2020-06-23	9.43x
2020-06-22	8.55x
2020-06-19	9.55x
2020-06-18	9.82x
2020-06-17	9.01x
2020-06-16	7.45x
2020-06-15	6.60x
2020-06-12	6.49x
2020-06-11	6.18x
2020-06-10	6.99x
2020-06-09	6.87x
2020-06-08	6.99x
2020-06-05	7.12x
2020-06-04	7.06x
2020-06-03	6.99x
2020-06-02	6.95x
2020-06-01	6.93x
2020-05-29	6.99x
2020-05-28	6.80x
2020-05-27	6.80x
2020-05-26	7.14x
2020-05-22	6.87x
2020-05-21	6.80x
2020-05-20	6.95x
2020-05-19	6.89x
2020-05-18	6.85x
2020-05-15	6.77x
2020-05-14	6.11x
2020-05-13	6.34x
2020-05-12	7.04x
2020-05-11	7.04x
2020-05-08	6.93x
2020-05-07	7.12x
2020-05-06	7.04x
2020-05-05	7.04x
2020-05-04	6.93x
2020-05-01	7.04x
2020-04-30	7.04x
2020-04-29	6.85x
2020-04-28	6.77x
2020-04-27	6.96x
2020-04-24	6.65x
2020-04-23	6.66x
2020-04-22	6.69x
2020-04-21	6.26x
2020-04-20	6.61x
2020-04-17	7.00x
2020-04-16	6.85x
2020-04-15	7.00x
2020-04-14	7.00x
2020-04-13	5.68x
2020-04-09	5.49x
2020-04-08	5.25x
2020-04-07	5.25x
2020-04-06	5.09x
2020-04-03	4.96x
2020-04-02	5.09x
2020-04-01	5.09x
2020-03-31	5.37x
2020-03-30	5.44x
2020-03-27	5.68x
2020-03-26	5.83x
2020-03-25	5.56x
2020-03-24	5.49x
2020-03-23	5.44x
2020-03-20	5.44x
2020-03-19	5.87x
2020-03-18	5.68x
2020-03-17	6.69x
2020-03-16	6.85x
2020-03-13	7.47x
2020-03-12	7.35x
2020-03-11	8.25x
2020-03-10	8.72x
2020-03-09	7.94x
2020-03-06	8.87x
2020-03-05	8.99x
2020-03-04	9.42x
2020-03-03	10.12x
2020-03-02	9.93x
2020-02-28	10.04x
2020-02-27	8.52x
2020-02-26	8.60x
2019-12-31	9.77x
2019-12-30	9.57x
2019-12-27	9.50x
2019-12-26	9.59x
2019-12-24	9.27x
2019-12-23	9.40x
2019-12-20	9.55x
2019-12-19	9.33x
2019-12-18	9.57x
2019-12-17	9.54x
2019-12-16	9.84x
2019-12-13	9.77x
2019-12-12	9.44x
2019-12-11	9.44x
2019-12-10	9.40x
2019-12-09	9.57x
2019-12-06	8.96x
2019-12-05	8.56x
2019-12-04	9.30x
2019-12-03	9.44x
2019-12-02	9.40x
2019-11-29	9.40x
2019-11-27	9.37x
2019-11-26	9.23x
2019-11-25	9.40x
2019-11-22	9.44x
2019-11-21	9.37x
2019-11-20	9.94x
2019-11-19	9.81x
2019-11-18	9.47x
2019-11-15	9.60x
2019-11-14	5.31x
2019-11-13	4.79x
2019-11-12	4.86x
2019-11-11	4.84x
2019-11-08	5.15x
2019-11-07	5.00x
2019-11-06	4.86x
2019-11-05	5.08x
2019-11-04	5.22x
2019-11-01	4.96x
2019-10-31	4.98x
2019-10-30	4.81x
2019-10-29	5.00x
2019-10-28	4.96x
2019-10-25	4.62x
2019-10-24	4.74x
2019-10-23	4.85x
2019-10-22	4.79x
2019-10-21	4.72x
2019-10-18	4.67x
2019-10-17	4.48x
2019-10-16	4.70x
2019-10-15	5.08x
2019-10-14	5.17x
2019-10-11	5.10x
2019-10-10	5.12x
2019-10-09	5.00x
2019-10-08	5.05x
2019-10-07	5.15x
2019-10-04	5.17x
2019-10-03	5.24x
2019-10-02	5.03x
2019-10-01	5.31x
2019-09-30	5.62x
2019-09-27	5.35x
2019-09-26	5.60x
2019-09-25	5.67x
2019-09-24	5.88x
2019-09-23	6.22x
2019-09-20	5.86x
2019-09-19	5.50x
2019-09-18	5.31x
2019-09-17	6.03x
2019-09-16	5.55x
2019-09-13	5.65x
2019-09-12	5.62x
2019-09-11	5.62x
2019-09-10	5.55x
2019-09-09	5.65x
2019-09-06	5.24x
2019-09-05	5.48x
2019-09-04	5.50x
2019-09-03	5.65x
2019-08-30	5.50x
2019-08-29	5.67x
2019-08-28	5.34x
2019-08-27	5.22x
2019-08-26	5.48x
2019-08-23	5.17x
2019-08-22	5.48x
2019-08-21	5.34x
2019-08-20	5.00x
2019-08-19	5.15x
2019-08-16	4.46x
2019-08-15	4.53x
2019-08-14	5.17x
2019-08-13	5.55x

EV/FCF Ratio: N/A

MDWD EV/FCF Ratio Chart

MDWD EV/FCF Ratio Metrics

MDWD Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

MDWD EV/FCF Ratio History

Related Metrics